Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 216

1.

Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson's disease in rats.

Karuppagounder SS, Madathil SK, Pandey M, Haobam R, Rajamma U, Mohanakumar KP.

Neuroscience. 2013 Apr 16;236:136-48. doi: 10.1016/j.neuroscience.2013.01.032. Epub 2013 Jan 26.

PMID:
23357119
2.

L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.

Saravanan KS, Sindhu KM, Senthilkumar KS, Mohanakumar KP.

Neurochem Int. 2006 Jul;49(1):28-40. Epub 2006 Feb 21.

PMID:
16490285
3.

Nitric oxide synthase inhibitors protect against rotenone-induced, oxidative stress mediated parkinsonism in rats.

Madathil KS, Karuppagounder SS, Haobam R, Varghese M, Rajamma U, Mohanakumar KP.

Neurochem Int. 2013 Apr;62(5):674-83. doi: 10.1016/j.neuint.2013.01.007. Epub 2013 Jan 23.

PMID:
23353925
4.

Sodium salicylate protects against rotenone-induced parkinsonism in rats.

Madathil SK, Karuppagounder SS, Mohanakumar KP.

Synapse. 2013 Aug;67(8):502-14. doi: 10.1002/syn.21658. Epub 2013 Mar 27.

PMID:
23447126
5.
6.

Behavioral alterations in rotenone model of Parkinson's disease: attenuation by co-treatment of centrophenoxine.

Nehru B, Verma R, Khanna P, Sharma SK.

Brain Res. 2008 Mar 27;1201:122-7. doi: 10.1016/j.brainres.2008.01.074. Epub 2008 Feb 9.

PMID:
18308296
7.
8.

Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease.

Verma R, Nehru B.

Neurochem Int. 2009 Nov;55(6):369-75. doi: 10.1016/j.neuint.2009.04.001. Epub 2009 Apr 16.

PMID:
19375462
9.

Mechanism of toxicity in rotenone models of Parkinson's disease.

Sherer TB, Betarbet R, Testa CM, Seo BB, Richardson JR, Kim JH, Miller GW, Yagi T, Matsuno-Yagi A, Greenamyre JT.

J Neurosci. 2003 Nov 26;23(34):10756-64.

10.

Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity.

Dabbeni-Sala F, Di Santo S, Franceschini D, Skaper SD, Giusti P.

FASEB J. 2001 Jan;15(1):164-170.

11.

Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease.

Höglinger GU, Carrard G, Michel PP, Medja F, Lombès A, Ruberg M, Friguet B, Hirsch EC.

J Neurochem. 2003 Sep;86(5):1297-307.

12.
13.

In vitro and in vivo evidences that antioxidant action contributes to the neuroprotective effects of the neuronal nitric oxide synthase and monoamine oxidase-B inhibitor, 7-nitroindazole.

Thomas B, Saravanan KS, Mohanakumar KP.

Neurochem Int. 2008 May;52(6):990-1001. doi: 10.1016/j.neuint.2007.10.012. Epub 2007 Oct 22.

PMID:
18164516
14.

Progressive loss of dopaminergic neurons induced by unilateral rotenone infusion into the medial forebrain bundle.

Norazit A, Meedeniya AC, Nguyen MN, Mackay-Sim A.

Brain Res. 2010 Nov 11;1360:119-29. doi: 10.1016/j.brainres.2010.08.070. Epub 2010 Aug 31.

PMID:
20807515
15.

Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.

Inden M, Kitamura Y, Tamaki A, Yanagida T, Shibaike T, Yamamoto A, Takata K, Yasui H, Taira T, Ariga H, Taniguchi T.

Neurochem Int. 2009 Dec;55(8):760-7. doi: 10.1016/j.neuint.2009.07.009. Epub 2009 Aug 6.

PMID:
19647776
16.

Neuroprotective effects of aldehyde dehydrogenase 2 activation in rotenone-induced cellular and animal models of parkinsonism.

Chiu CC, Yeh TH, Lai SC, Wu-Chou YH, Chen CH, Mochly-Rosen D, Huang YC, Chen YJ, Chen CL, Chang YM, Wang HL, Lu CS.

Exp Neurol. 2015 Jan;263:244-53. doi: 10.1016/j.expneurol.2014.09.016. Epub 2014 Sep 28.

17.

Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism.

Abdin AA, Hamouda HE.

Neuropharmacology. 2008 Dec;55(8):1340-6. doi: 10.1016/j.neuropharm.2008.08.033. Epub 2008 Sep 10.

PMID:
18817789
18.

Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats.

Lin CH, Huang JY, Ching CH, Chuang JI.

J Pineal Res. 2008 Mar;44(2):205-13. doi: 10.1111/j.1600-079X.2007.00510.x.

PMID:
18289173
19.

Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition.

Costa C, Belcastro V, Tozzi A, Di Filippo M, Tantucci M, Siliquini S, Autuori A, Picconi B, Spillantini MG, Fedele E, Pittaluga A, Raiteri M, Calabresi P.

J Neurosci. 2008 Aug 6;28(32):8040-52. doi: 10.1523/JNEUROSCI.1947-08.2008.

20.

Dopamine oxidation facilitates rotenone-dependent potentiation of N-methyl-D-aspartate currents in rat substantia nigra dopamine neurons.

Wu YN, Johnson SW.

Neuroscience. 2011 Nov 10;195:138-44. doi: 10.1016/j.neuroscience.2011.08.041. Epub 2011 Aug 23.

PMID:
21884756
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk